文献速递真实世界研究与卫生经济临床试验与 GCP流行病学与生物统计

在英国利用常规记录数据评估随机对照试验的结局:Access试验

Using routinely recorded data in the UK to assess outcomes in a randomised controlled trial: The Trials of Access.
PubMed 文献 · Trials · 2017-08-23

该研究以SANAD II试验为案例,评估在英国获取常规记录临床与非临床数据的可行性,98名参与者同意请求常规数据。结果显示,可获取全国性二级医疗临床数据和社会经济数据,但初级医疗数据无法针对个体获取,非临床来源数据获取未成功。作者提出改进常规记录数据在随机对照试验中获取与实施的建议。

要点

  • 可获取全国性二级医疗临床数据和社会经济数据,但申请流程存在限制。
  • 初级医疗数据由多个机构以去标识化方式记录,但针对特定个体的获取尚不可行。
  • 非临床来源数据(工作与养老金部、驾驶与车辆牌照局)获取未成功。

核心结论

  • 建议进一步研究评估常规记录数据的属性、评估公众认知,并制定策略合作改进研究中对常规记录数据的获取。

研究设计与样本

  • 案例研究为SANAD II试验,一项在英国开展的多中心、实用性、IV期随机对照试验,评估抗癫痫药物治疗新诊断癫痫的临床与成本效果。
  • 98名参与者提供书面同意以允许请求常规记录数据。
  • 通过正式申请向可用数据持有者请求参与者在SANAD II招募期间的常规记录临床与非临床数据,评估在随机对照试验期间获取常规记录数据的可行性。

主要发现

  • 二级医疗临床数据和社会经济数据在全国范围内记录且可获取,但申请流程存在限制。
  • 初级医疗数据由多个组织以去标识化方式记录,但针对特定个体的获取尚不可行。
  • 包括工作与养老金部和驾驶与车辆牌照局在内的非临床来源记录的数据获取未成功。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 二级医疗临床和社会经济数据的申请流程存在限制。
  • 初级医疗数据针对特定个体的获取尚不可行。
  • 非临床来源数据的获取未成功。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In the UK, routinely recorded data may benefit prospective studies including randomised controlled trials (RCTs). In an on-going study, we aim to assess the feasibility of access and agreement of routinely recorded clinical and non-clinical data compared to data collected during a RCT using standard prospective methods. This paper will summarise available UK routinely recorded data sources and discuss our experience with the feasibility of accessing routinely recorded data for participants of a RCT before finally proposing recommendations for improving the access and implementation of routinely recorded data in RCTs. METHODS: Setting: the case study RCT is the Standard and New Antiepileptic Drugs II (SANAD II) trial, a pragmatic, UK, multicentre, phase IV RCT assessing the clinical and cost-effectiveness of antiepileptic drug treatments for newly diagnosed epilepsy. PARTICIPANTS: 98 participants have provided written consent to permit the request of routinely recorded data. Study procedures: routinely recorded clinical and non-clinical data were identified and data requested through formal applications from available data holders for the duration that participants have been recruited into SANAD II. The feasibility of accessing routinely recorded data during a RCT is assessed and recommendations for improving access proposed. RESULTS: Secondary-care clinical and socioeconomic data is recorded on a national basis and can be accessed, although there are limitations in the application process. Primary-care data are recorded by a number of organisations on a de-identified basis but access for specific individuals has not been feasible. Access to data recorded by non-clinical sources, including The Department for Work and Pensions and The Driving and Vehicle Licensing Agency, was not successful. CONCLUSIONS: Recommendations discussed include further research to assess the attributes of routinely recorded data, an assessment of public perceptions and the development of strategies to collaboratively improve access to routinely recorded data for research. TRIAL REGISTRATION: International Standard Randomised Controlled Trials, ISRCTN30294119 . Registered on 3 July 2012. EudraCT No: 2012-001884-64. Registered on 9 May 2012.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Powell GA, Bonnett LJ, Tudur-Smith C, et al. Using routinely recorded data in the UK to assess outcomes in a randomised controlled trial: The Trials of Access. Trials. 2017. PMID: 28835254. doi:10.1186/s13063-017-2135-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。